Article
Two days after its merger announcement, US Oncology, Inc., reported that two class action lawsuits have been filed naming US Oncology and its directors as defendants.
Money Matters: How to invest during rising inflation
Money Matters: Informing your perspective on the bear market
Urology Times Money Matters: What you must do to survive down markets
Urology Times Money Matters: Annuity myths
UT Money Matters: Are REITs right for your portfolio?
UT Money Matters: Roth IRA conversions
Adding lutetium (177Lu) vipivotide tetraxetan to SOC improves rPFS in mHSPC
Lower-dose abiraterone offers viable alternative to standard-dose for mCRPC
Long-term data support radium-223 safety in mCRPC
Survey: New NMIBC treatments face slow uptake